Your browser doesn't support javascript.
loading
Bronchoalveolar Lavage Fluid Cellular Analysis and Radiologic Patterns in Patients With Fibrotic Interstitial Lung Disease.
Grant-Orser, Amanda; Asmussen, Michael; Marinescu, Daniel-Costin; Hague, Cameron J; Muller, Nestor L; Murphy, Darra T; Churg, Andrew; Wright, Joanne L; Al-Arnawoot, Amna; Bilawich, Ana-Maria; Bourgouin, Patrick; Cox, Gerald; Durand, Celine; Elliot, Tracy; Ellis, Jennifer; Fisher, Jolene H; Fladeland, Derek; Goobie, Gillian C; Guenther, Zachary; Haider, Ehsan; Hambly, Nathan; Huynh, James; Karjala, Geoffrey; Khalil, Nasreen; Kolb, Martin; Leipsic, Jonathon; Lok, Stacey; MacIsaac, Sarah; McInnis, Micheal; Manganas, Helene; Marcoux, Veronica; Mayo, John; Morisset, Julie; Scallan, Ciaran; Sedlic, Tony; Shapera, Shane; Sun, Kelly; Tan, Victoria; Wong, Alyson W; Zheng, Boyang; Ryerson, Christopher J; Johannson, Kerri A.
Afiliación
  • Grant-Orser A; Department of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: Amanda.grant-orser@mail.mcgill.ca.
  • Asmussen M; Department of Biology, Mount Royal University, Calgary, AB, Canada.
  • Marinescu DC; Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
  • Hague CJ; Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Muller NL; Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Murphy DT; Department of Radiology, St James' Hospital, Dublin, Ireland.
  • Churg A; Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Wright JL; Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada.
  • Al-Arnawoot A; Department of Radiology, McMaster University, St. Joseph's Healthcare, Hamilton, ON, Canada.
  • Bilawich AM; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Bourgouin P; Department of Radiology, Radiation Oncology and Nuclear Medicine, University of Montreal, QC, Canada.
  • Cox G; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Durand C; Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
  • Elliot T; Department of Radiology, University of Calgary, AB, Canada.
  • Ellis J; Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Fisher JH; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Fladeland D; Department of Medical Imaging, University of Saskatchewan, Saskatoon, SK, Canada.
  • Goobie GC; Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada; Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
  • Guenther Z; Department of Radiology, University of Calgary, AB, Canada.
  • Haider E; Department of Radiology, McMaster University, St. Joseph's Healthcare, Hamilton, ON, Canada.
  • Hambly N; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Huynh J; Department of Radiology, University of Calgary, AB, Canada.
  • Karjala G; Department of Medical Imaging, University of Saskatchewan, Saskatoon, SK, Canada.
  • Khalil N; Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Kolb M; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Leipsic J; Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Lok S; Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
  • MacIsaac S; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • McInnis M; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada; University Medical Imaging Toronto, Toronto General Hospital, Toronto, ON, Canada.
  • Manganas H; Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Marcoux V; Department of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
  • Mayo J; Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Morisset J; Department of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Scallan C; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Sedlic T; Department of Radiology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Shapera S; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Sun K; Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Tan V; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Wong AW; Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
  • Zheng B; Division of Rheumatology, McGill University, Montreal, QC, Canada.
  • Ryerson CJ; Department of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
  • Johannson KA; Department of Medicine, University of Calgary, Calgary, AB, Canada; Snyder Institute for Chronic Disease, University of Calgary, Calgary, AB, Canada.
Chest ; 2024 Aug 22.
Article en En | MEDLINE | ID: mdl-39179174
ABSTRACT

BACKGROUND:

Bronchoalveolar lavage (BAL) cellular analysis is often recommended during the initial diagnostic evaluation of fibrotic interstitial lung disease (ILD). Despite recommendation for its use, between-center heterogeneity exists and supportive data concerning the clinical utility and correlation of BAL findings with radiologic features or patterns remain sparse. RESEARCH QUESTION In patients with fibrotic ILD, are BAL findings associated with radiologic features, patterns, and clinical diagnoses? STUDY DESIGN AND

METHODS:

Patients with fibrotic ILD who underwent BAL for diagnostic evaluation and who were enrolled in the prospective Canadian Registry for Pulmonary Fibrosis were re-reviewed in a standardized multidisciplinary discussion (MDD). BAL was categorized according to guideline-recommended thresholds, and using thresholds of lymphocytosis > 20% and neutrophils > 4.5%. High-resolution CT (HRCT) scans were scored (blinded to clinical data) for specific features and percentage lung involvement. Radiologists classified HRCT scans according to guideline-defined patterns for idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis (fHP); then, MDD diagnoses were assigned, considering all available data.

RESULTS:

Bronchoscopy with cellular analysis was performed in 209 of 1,593 patients (13%). Lymphocyte % was weakly negatively correlated with total fibrosis % (r = -0.16, P = .023) but not statistically significantly correlated with ground glass opacity % (r = 0.01, P = .94). A mixed BAL pattern was the most frequent in all radiologic patterns (range, 45%-69%), with a minority classifiable according to BAL guidelines. BAL lymphocytosis appeared with similar frequency across HRCT patterns of fHP (21%) and usual interstitial pneumonia (18%). Only 5% of patients with MDD-based fHP had a guideline-defined isolated lymphocytosis > 15%.

INTERPRETATION:

BAL cellular analyses did not significantly correlate with radiologic features, guideline patterns, or MDD-based diagnoses. Ground glass opacities are often interpreted to represent pulmonary inflammation, but were not associated with BAL lymphocytosis in this cohort.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Chest Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Chest Año: 2024 Tipo del documento: Article